http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105147663-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 2015-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105147663-B
titleOfInvention Application of the cyanidenon in intervention school-based is inhibited bacteria
abstract The present invention relates to pharmaceutical technology field, the present invention provides application of the cyanidenon in intervention school-based is inhibited bacteria, and provides the minimum effective concentration with application value for the application, and the biofilm formating inhibitor medically to prepare special provides reference;Cyanidenon is preparing the application in reducing the pathogenic medicine of staphylococcus aureus virulence factor;Application of the cyanidenon in the medicine for suppressing staphylococcus aureus hla and agrA genetic transcription is prepared.The present invention also provides a kind of pharmaceutical composition for suppressing Staphylococcus Aureus Biofilm and being formed, wherein contain cyanidenon, the pharmaceutical composition, only need minimal amount of cyanidenon just can be by effectively suppressing the intervention school-based of staphylococcus aureus, suppress its biofilm formation, it is reduced in anti-infective therapy, lapses to risk to highly drug resistant biomembrane infection, the preparation formed medically to prepare special suppression Staphylococcus Aureus Biofilm provides valuable reference.
priorityDate 2015-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426565247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1794427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423356279
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID46964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68561600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428054790
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID48386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560248
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID41568
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID41568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11870308
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5318517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426132826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507594
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID46964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7067324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281643
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2G1D3
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID137693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51521831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14969
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID137693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412055625
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID48386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11802
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523593
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1280

Total number of triples: 42.